Midkine Can Be Evaluated as a New Ovarian Reserve Marker at Polycystic Ovary Syndrome Cases Except for Unexplained Infertility Cases

Fertility and Sterility - Netherlands
doi 10.1016/j.fertnstert.2018.07.914
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Clinical Observation of 242 Cases of Polycystic Ovary Syndrome

Yangtze Medicine
2018English

Concomitant Hypothyroidism Does Not Impact Ovarian Reserve Parameters in Polycystic Ovary Syndrome

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2018English

Elevated Serum Mannose Levels as a Marker of Polycystic Ovary Syndrome

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Letrozole Versus Clomiphene for Infertility in the Polycystic Ovary Syndrome

Obstetrical and Gynecological Survey
MedicineGynecologyObstetrics
2014English

Anti-Mullerian Hormone as a Marker for Diagnosis of Polycystic Ovary Syndrome and Its Function After Laparoscopic Ovarian Diathermy

The Egyptian Journal of Fertility of Sterility
2008English

Infertility Treatment in Patients With Polycystic Ovary Syndrome (PCOS)

Journal of Fertilization: In vitro
2012English

1° Infertility Diagnosis: Polycystic Ovarian Syndrome + Male Factor

English

Ultrasonographic Guided Ovarian Stroma Hydrocoagulation for Ovarian Stimulation in Polycystic Ovary Syndrome

Acta Obstetricia et Gynecologica Scandinavica
MedicineGynecologyObstetrics
2001English

Polycystic Ovary Syndrome May Be an Autoimmune Disorder

Scientifica
AgriculturalEnvironmental ScienceBiological Sciences
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy